D

Drugs for Neglected Diseases initiative - DNDi

384 employees

Drugs for Neglected Diseases initiative is a collaborative, patients’ needs-driven, non-profit drug research and development organization

Basic info

Industry

research services

Sectors

Biotechnology
Non Profit
drug development
human African trypanosomiasis
open innovation
dengue
research
R&D
malaria
medicine
filarial diseases
not-for-profit
mycetoma
leishmaniasis
Chagas disease
paediatric HIV
ntds
hepatitis C
neglected tropical diseases
Medical
neglected diseases

Date founded

2003

Funding rounds raised

D

Drugs for Neglected Diseases initiative - DNDi raised undisclosed on September 28, 2020

Investors: Fundación Bancaria ”la Caixa”

FAQ